New name, but same old problems for Posimir as FDA hits Durect again

Ben Adams Durect may have changed the name of its post-pain gall bladder surgery drug from "Posidur" to "Posimir" this year, but this has not stopped its run of ...

Pain Therapeutics, Durect shares nosedive on haziness for Pfizer’s Remoxy

Ryan McBride Pfizer hasn't decided whether to pursue additional work to seek FDA approval for the storied painkiller Remoxy, and faces a decision on the continuance of the program, ...
© 2017 Global Regulatory Science. All rights reserved. Site Admin · Entries RSS · Comments RSS